[ Price : $8.95]
Taysha Gene Therapies says it is discontinuing the development of its gene therapy TSHA-120 program as a treatment for giant axona...[ Price : $8.95]
UCB says its BLA for plaque psoriasis drug bimekizumab is facing another FDA review extension.[ Price : $8.95]
Federal Register notice: FDAs Office of Womens Health and Office of Clinical Pharmacology announces a 10/11 public workshop: Menop...[ Price : $8.95]
Medline Industries recalls its Hudson RCI Addipak unit dose vial, 0.9% full normal saline solution (Lot 3B085) due to sterility co...[ Price : $8.95]
Federal Register notice: CBER requests information from stakeholders about critical scientific challenges and opportunities to adv...[ Price : $8.95]
FDA warns Miramar, FL-based Kimera Labs about illegally manufacturing and distributing unapproved exosome products that have CGMP ...[ Price : $8.95]
FDA publishes a draft CDRH strategic plan for medical device international harmonization.[ Price : $8.95]
Three Ropes & Gray attorneys analyze three FDA draft guidances intended to modernize the 510(k) program, saying they are likely to...